In the most recent trading session, Novavax (NVAX) closed at $10.11, indicating a +1.1% shift from t

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The lat

Cancer vaccine momentum is doing the work for Moderna (NASDAQ:MRNA | MRNA Price Prediction) once aga

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is w

In the most recent trading session, Novavax (NVAX) closed at $9.42, indicating a +1.29% shift from t

Novavax NASDAQ: NVAX executives outlined the company's transition from a COVID-19 vaccine-focused bu

Novavax, Inc. (NVAX) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Novavax NASDAQ: NVAX outlined its strategy to expand the use of its Matrix-M adjuvant platform throu

Novavax, Inc. (NVAX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcri

GAITHERSBURG, Md., Sept. 2, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that c

Novavax Inc. (NASDAQ:NVAX) shares are trading higher. Strength may be due to an increase in investor

Novavax is rising on investors reaction to an unconfirmed rumor that Matrix-M has a favorable safety

Retail traders are treating Novavax as a cancer-vaccine play today, but the price action shows a sin

Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as tr

Shares of Novavax Inc. (NASDAQ:NVAX) are trading higher Monday morning. The stock is extending its 3

Shares of Novavax are trading higher Monday, extending its 30% monthly gains on COVID-19 vaccine app

U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of A

Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U

Novavax, Inc.'s (NASDAQ:NVAX) partners have received approvals for the Nuvaxovid™ formulation to

COVID-19 remains a public health challenge, particularly among older adults and high-risk population

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligi

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi and ​Pfizer-BioNTech's update

Drug stock Novavax Inc (NASDAQ:NVAX) is trading 2.8% lower at $9.18 this afternoon, pulling back fro

Shares of Novavax are trading higher Tuesday morning as buying interest continues across late-stage

Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on posi

A third drug stock making plenty of progress in today's trading

Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinica

https://youtu.be/H_RititNE8U

Novavax beat Q2 earnings and revenue estimates, raises its 2026 adjusted revenue outlook, cuts expen

Novavax NASDAQ: NVAX reported second-quarter 2026 revenue of $57 million and a net loss of $53 milli

Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,

Novavax shares are up on Monday following a licensing agreement with Pfizer for the use of its Matri

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, wi

Retail investors are preparing for another busy week of earnings season with more than 1,600 compani

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease

U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultane

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milesto

FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biote

https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines